CT011
IND- Indications
- Hematologic malignancies
Company intelligence / Profile preview
GoBroad Healthcare Group operates a network of specialized hospitals focused on the diagnosis and treatment of complex diseases—especially solid tumors and hematological malignancies. The group has pioneered multidisciplinary care models integrating conventional therapies with innovative diagnostics. It runs several clinical trials in partnership with global pharma/biotech companies. Its flagship Beijing GoBroad Hospital opened in July 2023 as a major research-driven institution supporting translational medicine from discovery through application. The group’s work has brought new hope to thousands of patients battling life-threatening diseases
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GoBroad Healthcare Group.